Herbas VPB

Print
EN | LT
LT - COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR
EN - COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/444 (2006.01)
A61K 31/444 (2013.01)
A61K 31/506 (2006.01)
A61K 31/517 (2013.01)
A61K 45/00 (2006.01)
A61K 31/5377 (2013.01)
A61P 35/00 (2006.01)
A61P 35/00 (2018.01)
A61P 35/02 (2006.01)
A61K 45/06 (2013.01)
A61P 43/00 (2006.01)
A61K 31/517 (2006.01)
A61K 31/5377 (2006.01)
A61K 45/06 (2006.01)
European patent
(11) Number of the document 3603638
(13) Kind of document T
(96) European patent application number 18770641.1
Date of filing the European patent application 2018-03-23
(97) Date of publication of the European application 2020-02-05
(45) Date of publication and mention of the grant of the patent 2023-12-13
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/JP2018/011560
Date 2018-03-23
PCT application publication
(87) Number WO 2018/174219
Date 2018-09-27
Priority applications
(30) Number Date Country code
2017058858 2017-03-24 JP
Inventors
(72)
JIMBO, Takeshi , JP
Grantee
(73) Daiichi Sankyo Company, Limited , 3-5-1, Nihonbashi-honcho Chuo-ku, Tokyo 103-8426, JP
Title
(54) COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR
  COMBINATION THERAPY TECHNIQUE FOR AXL INHIBITORY AGENT AND EGFR TYROSINE KINASE INHIBITOR